Twitter has been a hotbed for the burgeoning insulin access movement and activism surrounding other medical conditions. For people with diabetes, the platform has helped propel concern about insulin prices into policy. Can it continue to win with hashtags?
The first installment of InvestigateTV and KHN’s “Costly Care” series explores one California mother’s experience struggling to get reimbursed for midwifery care and the differences between providers that may determine whether insurance covers them.
KHN shares the cream of the crop of creative valentines about health policy submitted by readers and tweeters. Our favorite is anointed with an original illustration and bragging rights as “the one.”
When Medicare stops paying for a pricey drug that prolongs life, an Ohio man considers giving up treatment to spare his family enormous debt.
As Montana officials seek to make nonprofit hospitals prove the benefits they provide the community justify their tax exemptions, industry leaders propose their own changes — which state officials say would further limit the state’s authority.
As a money-saving strategy, emergency rooms are turning to nurse practitioners, physician assistants, and other staffers who earn far less than physicians.
Insurers, employers, and taxpayers will all be affected as drug manufacturers move these products to the commercial market.
A private equity firm bought a birth center and then shut it down. The community brought it back as a nonprofit.
Our partners at PolitiFact fact-checked a range of President Joe Biden’s statements, including key health-related comments.
As he takes the reins of the Senate Health, Education, Labor & Pensions Committee, the independent from Vermont and implacable champion of “Medicare for All” maps out his strategy for negotiating with Republicans — and Big Pharma.
